🔗 Share this article TikTok Content Creators Fueling Unofficial Trade for Unlicensed Weight-Loss Medication A shadow economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings. Experimental Drug Gaining Popularity Online The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are encouraged to message these profiles directly for source information, while also receiving discount codes. Active Trade on Messaging Platforms Separately, a flourishing market exists on messaging services, where groups with thousands of members share comparison images, administration instructions and assertions of rapid UK delivery. Vendors market the drug there before redirecting buyers to WhatsApp for transactions. Learning About Retatrutide This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic. Healthcare Professionals Express Concerns However, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to individuals injecting products of uncertain source. Some professionals said the popularity for retatrutide could be linked to the rising price of licensed slimming products such as Mounjaro. Legal Position and Implementation Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012. Several influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and consumer regulations, risking penalties, legal action or imprisonment. Platform Response and Content Removal Based on TikTok, the service has taken down violative material and banned related hashtags and search suggestions. The organization stated it was dedicated to maintaining the service secure and allocating resources in strengthening enforcement strategies. Online Trading Operations Investigations also found communities with up to nine thousand members selling the experimental drug using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, populated with photos of slimming results, positive testimonials and detailed guides for mixing or injecting at home. After moments of joining one community, a vendor posted WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about weight, medical conditions or past usage. Product Information and Costs Inside these groups, messages display dark colored packages with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.” Buyers can select between powder vials, prepared at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how long a injector should be used, vendors give conflicting responses ranging from a several days to “depends on your body”. Service Oversight and Security Actions A representative for the messaging service said it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”. Healthcare Professional Cautions “People are administering substances they can’t verify. Even if the research behind retatrutide is sound, these online versions may not contain what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U. A medical professional of an online medical service connected the increase in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained. Her team has previously encountered patients harmed by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.” Manufacturer Statement A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company experimental product not yet authorized … may subject users to possibly serious medical dangers”.